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Background: Reliable identification of Mycobacterium tuberculosis infec-
tion or tuberculosis (TB) disease in young children is vital to assure ade-
quate preventive and curative treatment. The tuberculin skin test (TST) and 
IFNγ-release assays may supplement the diagnosis of pediatric TB as cases 
are typically bacteriologically unconfirmed. However, it is unclear to what 
extent the performance of TST and QuantiFERON-TB Gold In-Tube (QFT; 
Cellestis’ IFNγ-release assay test) depends on the demographic, clinical and 
nutritional characteristics of children in whom they are tested.
Methods: During a 2-year prospective observational study of 4382 neo-
nates in Southern India, children with suspected TB were investigated and 
classified by a standard TB diagnostic algorithm.
Results: Clinical TB was diagnosed in 13 of 705 children referred for case 
verification with suspected TB. TST and QFT had a susceptibility for clini-
cal TB of 31% and 23%, respectively, in this group. Children <2 years were 
more likely to test QFT indeterminate. A height-for-age Z score within the 
lowest quartile increased the odds ratio (OR) for a positive or indeterminate 
QFT result [OR 2.46 (1.19–5.06), OR 3.08 (1.10–8.58)], whereas the OR 
for a positive TST was reduced with a weight-for-height Z score within the 
lowest quartile [OR 0.17 (0.06–0.47)].
Conclusion: The sensitivities of the TST and QFT for clinical TB in children 
<3 years of age were equally poor in this population. Stunted children were 
more susceptible to Mycobacterium tuberculosis infection and more prone 
to indeterminate QFT results. TST was less reliable in children with wasting.
Key Words: tuberculosis, tuberculin skin test, interferon gamma release 
assay, malnutrition, child. multivariate analyses
(Pediatr Infect Dis J 2014;33:e260–e269)
Children <2 years of age at the time of infection typically develop tuberculosis (TB) disease because of primary infec-
tion and not as a result of reactivation. Their risk of progression 
to TB and for developing severe disease is high. Therefore, reli-
able identification of Mycobacterium tuberculosis (MTB) infec-
tion or TB in young children is vital to assure adequate preventive 
and curative treatment. Pediatric TB often remains unconfirmed 
because of paucibacillary disease and technical difficulties in 
obtaining adequate specimens. Therefore, evidence of MTB infec-
tion by a positive tuberculin skin test (TST) or IFNγ-release assay 
(IGRA) may be used as a supplement in diagnosis.1 World Health 
Organization (WHO) recommends the use of TST over IGRAs in 
children in low- to middle-income countries as TST is cheaper and 
evidence suggests little difference in sensitivity.2 A trend towards 
lower sensitivity of all tests in children <5 years was highlighted 
in a recent meta-analysis, but the conclusion was limited by few 
included subjects.3 In addition, it is unclear to what extent the per-
formance of TST and IGRAs depends on demographic, clinical and 
nutritional characteristics in young children.
In this study, we first evaluated the performance of TST and 
QFT in diagnosing clinical TB, in a cohort of children <3 years 
in a rural setting in Southern India. We then assessed the associa-
tions between TST and QFT results and sociodemographic, clini-
cal and nutritional (intrauterine and postnatal) characteristics in 
the same cohort.
METHODS
Study Design and Setting
This study was nested within the Neonatal Cohort Study 
(NCS), a population-based prospective study of 4382 Calmette-Guérin 
bacillus-vaccinated neonates cluster randomized to active (2215) or 
passive (2167) surveillance for 2 years, in the Palamaner Taluk, India 
(3.200°N, 72.7500°E, altitude 683 m), from April 2007 to September 
2010. Enrollment and consent procedures are previously described.4 
The NCS covered a total population of ~400,000, with an estimated 
TB incidence of 136/100,000 (Andhra Pradesh, 2010).5
The present study is cross-sectional and included children 
enrolled in the NCS and evaluated for TB at the Case Verification 
Ward (CVW) at Emmaus Swiss Hospital, during the follow-up 
period. Referral criteria were either (1) exposure to a known TB 
case within the last year; (2) respiratory/infectious symptoms or 
(3) failure to thrive (FTT) defined as any of the following: (i) loss 
of weight or no weight gain for 2 consecutive visits; (ii) down-
ward crossing of 2 percentile lines on the weight-for-age growth 
chart or (iii) weight that tracked consistently below the 3rd per-
centile in the weight-for-age growth chart6 or (4) a TST ≥10 mm 
at study closeout.
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The study was approved by the institutional review board at 
St. John’s Medical College, Bangalore, India, an independent ethics 
review committee and the Ministry of Health Screening Committee, 
Government of India (No. 5/8/9/60/20006-ECD-1 dt.10.11.2006).
Diagnostic Assessment
Clinical and anthropometric data were recorded. A chest 
radiograph (CXR), anterioposterior view, was interpreted by 3 inde-
pendent radiologists. Agreement by 2 radiologists was required to 
classify a CXR as consistent with TB. A TST was performed by a 
trained nurse/doctor (2 TU/0.1 mL tuberculin; Span Diagnostics Ltd, 
Gujarat, India) and read after 48 hours. Peripheral blood (3 mL) was 
drawn for the QFT (Cellestis/Qiagen, Carnegie, Victoria, Australia) 
which was performed according to the manufacturer’s instructions.
Gastric aspirates and induced sputa were collected on 2 con-
secutive days for fluorescent microscopy (Auramine) and culture 
on solid (Löwenstein-Jensen) and liquid (Mycobacterial Growth 
Indicator Tube, BD) medium. Positive results were confirmed by 
Ziehl-Neelsen staining and speciated using the HAIN kit (Geno-
Type MTBC, Ver1, Hain Life Sciences, Germany). Direct PCR (The 
COBAS TaqMan MTB Test, Roche 2007) was done on all culture-
negative specimens in children with CXR consistent with TB. The 
HIV status was not assessed, but data from a household contact study 
conducted in the same study area during the period 2010–2012 found 
a HIV prevalence <1% (TB Trials Study Group, unpublished data).
Clinical Outcomes
A structured diagnostic algorithm including TST result (but 
not QFT), classified the children as having definite TB, probable 
TB or not TB. Clinical TB included definite TB [positive culture or 
polymerase chain reaction (PCR)] and probable TB (CXR sugges-
tive of TB and ≥1 of the following: known TB exposure, fever and/
or cough ≥2 weeks, FTT and TST ≥10 mm).
Statistical Analysis
Low birth weight (<2500 g) and being small for gestational 
age (SGA: Weight-for-gestational age <10th percentile)7 were used 
as indicators of intrauterine nutritional status. The WHO child 
growth standard Z scores were dichotomized using the cutoff <−2, 
which defines wasting 2 [weight-for-height Z-score (WHZ)], stunt-
ing [height-for-age Z-score (HAZ)] and underweight [weight-for-
age Z score (WAZ) and BMI-for-age Z score (BAZ)].6 Equal to the 
WHO definition, hemoglobin <10 g/100 mL defined the cutoff for 
moderate-severe anemia.8 TST and QFT were handled as categori-
cal variables; TST (binary), cutoff ≥10 mm,9 QFT in 3 categories: 
positive (≥0.35 IU/mL), negative (<0.35 IU/mL) and indetermi-
nate. Categorical data were compared by Pearson’s χ2 with Yates 
Continuity Correction or Fisher’s exact test, where appropriate. 
Kappa statistics were used in the concordance analyses of TST and 
QFT result and evaluated according to McGinn et al.10
Because malnutrition was left-shifted in the study popu-
lation, children within the lowest quartile were considered mal-
nourished in new dichotomous variables that were included in the 
univariate and multivariate analyses (cutoffs: WHZ <−2.59, HAZ 
<−2.14, WAZ <−2.63 and BAZ <−2.51). Univariate associations 
between positive TST and/or QFT outcomes (indeterminate QFT 
results excluded) and surveillance arm (active or passive), gender, 
birth weight, SGA, age, socioeconomic factors (mothers/fathers 
education, housing, cooking fuel), known TB exposure, symp-
toms, nutritional status (WHZ, HAZ, WAZ, BAZ, anemia) and 
isolated Non-tuberculous mycobacteria (NTMs), were assessed 
by logistic regression. Variables with significant univariate asso-
ciations with the TST and/or QFT outcomes were considered for 
inclusion in the multivariate model if they could be assumed to 
have a casual impact on the outcomes. These assumed that causal 
relationships were based on the literature and drawn by principles 
of a directed acyclic graph (DAG).11 Notably, as the positive TST 
and/or QFT outcomes are imperfect readouts of the clinical TB 
outcome (clinical TB disease, MTB infection or no infection/dis-
ease) for which there is no gold standard, we chose to illustrate 
the variables relationship both to the clinical TB outcome and 
the positive TST and/or QFT outcomes (Fig. 1; causal relation-
ships are indicated with arrows). The variables impact on clinical 
TB influence on the child’s susceptibility for MTB infection and 
disease, whereas the variables impact on a positive TST and/or 
QFT result influence on the ability of the tests to correctly reflect 
the clinical TB outcome (test performance). Following the DAG 
principle, ancestor variables (variables that is a cause of another 
FIGURE 1. A DAG illustrating the causal 
relationships between the determinants 
for the outcomes clinical TB and positive 
TST and/or QFT. A causal relationship 
between a determinate (variable names 
listed in parenthesis) and an outcome 
is indicated with arrows. Ancestors 
(variables that is a cause of another 
variable more closely linked to the 
outcome) and descendants of the 
outcome not included in the multivariate 
models are in italic. Variables significantly 
associated to the outcomes in univariate 
analysis are in bold. Dashed arrows 
indicate more uncertain relationships.
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variable more closely linked to the outcome) and descendants of 
the outcome were not included in the multivariate models.11 These 
considerations left age, TB exposure, WHZ, HAZ and NTM pres-
ence in the multivariate model together with gender that is rou-
tinely included. WHZ and HAZ represent different entities of mal-
nutrition and important collinearity or interaction was not found 
when all possible 2-way interactions in each of the multivariate 
models were tested. Regarding the indeterminate QFT outcome, 
the assumed causal relationship is different (Fig. 2). Being pri-
marily the result of inadequate mitogen responses, this outcome 
is not specific for clinical TB outcome, but rather affected by all 
physiological conditions interfering with T-cell responses in gen-
eral (Fig. 2). Accordingly, known TB was not considered relevant 
whereas symptoms of any duration (categories defined in Table 1) 
were included because of previous reports.12 Missing data for each 
variable can be deduced from Table 2.
All P values were calculated using 2-tailed tests and P < 0.05 
was considered significant. Analyses were conducted using PASW 
Statistics version 18.0, 2009. SPSS Inc. Chicago, IL.
RESULTS
Characteristics of the Study Population
Of 746 children investigated at the CVW, 86 children (11.5%) 
had known TB exposure. Two or more referral criteria were present in 
123 (16.5%). Of 623 children with a single referral criteria present, 
FIGURE 2. A DAG illustrating the causal 
relationships between the determinants 
for the outcome indeterminate QFT. A 
causal relationship between a determinate 
(variable names listed in parenthesis) and 
an outcome is indicated with arrows. 
Ancestors (variables that is a cause of 
another variable more closely linked to 
the outcome) and descendants of the 
outcome not included in the multivariate 
models are in italic. Variables significantly 
associated to the outcomes in univariate 
analysis are in bold. Dashed arrows 
indicate more uncertain relationships.
TABLE 1. Unadjusted and Adjusted OR Estimates and 95% CI for the 
Significant Associations Between a Positive TST and QFT as Dependant 
Variable and Sociodemographic, Clinical, Nutritional and Mycobateriological 
Factors (Not M. Tuberculosis)*
TST ≥ 10 mm and QFT ≥ 0.35 IU/mL vs.  
Other Combinations of TST and QFT Test  
Results (N = 666)
Unadjusted
OR (95% CI)
Adjusted
OR (95% CI)
Surveillance
  Active 0.14 (0.05–0.37)
Gender
  Male 1.16 (0.45–2.98) 1.42 (0.51–3.95)
Age categories
  0–11 months 0.12 (0.03–0.42) 0.10 (0.02–0.34)
  12–23 months 0.08 (0.02–0.24) 0.07 (0.02–0.25)
  ≥24 months†
Known contact with TB case
  Yes 5.34 (2.00–14.23) 9.41 (2.93–30.2)
FTT
  Yes 0.17 (0.07–0.45)
WHZ
  <−2.59 (n = 173) 2.19 (0.92–5.23) 2.48 (0.98–6.28)
HAZ
  <−2.14 (n = 176) 3.17 (1.24–8.12) 3.46 (1.19–10.0)
NTM
  ≥1 positive specimen 0.70 (0.23–2.09) 0.69 (0.21–2.24)
Adjusted OR estimates and 95% CI are shown for all variables included in the multivariate model. OR estimates 
and 95% CI for variables not included in the table are available on request.
*Binary logistic regression was applied. CI that do not overlap the null value OR = 1 are shown in bold.
†Reference group.
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TABLE 2. Characteristics of Children Referred to the CVW Classified According to the Diagnostic TB Algorithm (n = 705)*
Total Clinical TB† No TB
P Valuen = 705 (%) n = 13 (%) n = 692 (%)
Surveillance arm (N = 705)
  Active 609 (86.4) 10 (76.9) 599 (86.6) 0.40
No of visits to the CVW (N = 705)
  1 visit 663 (94.0) 10 (76.9) 653 (94.4) 0.07
  2 visits 40 (5.7) 3 (23.1) 37 (5.3)
  3 visits 2 (0.3) — 2 (0.3)
Sex (N = 705)
  Male 374 (53.0) 7 (53.8) 367 (53.0) 1.00
Birth weight (g; N = 703)
  Mean 2807 2735 2809 0.13
  Min-max 1500–4500 (1500–4000) (2000–4500)
  SGA 72 (10.2) 3 (23.1) 69 (10.0) 0.14
Age (months; N = 705)
Mean 14.8 16.8 14.8 0.84
  Min-max (1–35) (8–28) (1–35)
  0–11 months 220 (31.2) 4 (30.8) 216 (31.2) 0.53
  12–23 months 392 (55.6) 6 (46.2) 386 (55.8)
  ≥ 24 months 93 (13.2) 3 (23.1) 90 (13.0)
Mothers education (N = 705)
  High school or higher 143 (20.3) 1 (7.7) 142 (20.5) 0.37
  Primary, secondary 351 (49.8) 9 (69.2) 342 (49.4)
  Illiterate 211 (29.9) 3 (23.1) 208 (30.1)
Fathers education (N = 701)
  High school or higher 195 (27.7) 1 (7.7) 194 (28.0) 0.18
  Primary, secondary 372 (52.8) 8 (61.5) 364 (52.6)
  Illiterate 134 (19.0) 4 (30.8) 130 (18.8)
Housing (wall; N = 705)
  Bricks 540 (76.6) 11 (84.6) 529 (76.4) 0.74
  Other 165 (23.4) 2 (15.4) 163 (23.6)
Cooking fuel (N = 705)
  Electricity (none) or gas 49 (7.0) — 49 (7.1) 1.00
  Other 656 (93.0) 13 (100.0) 643 (92.9)
Known contact with TB case (N = 705)
  Yes 85 (12.1) 2 (15.4) 83 (12.0) 0.66
Symptoms (fever and/or cough; N = 705)
  2 of 2 symptoms 145 (20.6) 3 (23.1) 142 (20.5) 1.00
  1 of 2 symptoms 142 (20.1) 2 (15.4) 140 (20.2)
  None 418 (59.3) 8 (61.5) 410 (59.2)
Fever and/or cough ≥ 2 weeks (N = 705)
  Yes 175 (24.8) 4 (30.8) 171 (24.7) 0.75
FTT (N = 705)
  Yes 537 (76.2) 8 (61.5) 529 (76.4) 0.20
CXR (AP; N = 704)
  Consistent with TB 11 (1.6) 11 (84.6) — <0.0005
  Abnormal, not TB 12 (1.7) — 12 (1.7)
  Normal 681 (96.6) 2 (15.4) 679 (98.1)
NTM (N = 705)
  ≥1 positive specimen 166 (23.5) 2 (15.4) 164 (23.7) 0.74
WHZ (N = 703)
  Mean −1.80 −1.86 −1.80 0.38
  Min-max −4.93 to 3.61 (−4.06 to 1.59) (−4.93 to 3.61)
  <−2 (wasting) 305 (43.3) 7 (53.8) 298 (43.1) 0.57
HAZ (N = 703)
  Mean −1.25 −2.23 −1.24 0.81
  Min-max −6.32 to 3.13 (−2.95 to 0.35) (−6.32 to 3.13)
  <−2 (stunting) 197 (27.9) 6 (46.2) 191 (27.6) 0.21
WAZ (N = 705)
  Mean −1.95 −2.11 −1.95 0.47
  Min-max −5.00 to 1.67 (−3.99 to 1.33) (−5.00 to 1.67)
  <−2 (underweight) 354 (50.2) 8 (61.5) 346 (50.0) 0.58
BAZ (N = 703)
  Mean −1.70 −1.70 −1.70 0.44
  Min-max −4.95 to 4.63 −3.86 to 1.55 −4.95 to 4.63
  <−2 (underweight) 284 (40.3) 7 (53.8) 277 (40.0) 0.40
Hgb (g/100 mL; N = 601)
  Mean 10.7 10.0 10.7 0.16
  Min-max 4.0–18.9 8.0–11.6 4.0–18.9
  <10 g/100 mL (moderate-severe anemia) 197 (32.8) 6 (54.5) 191 (32.4) 0.11
(Continued)
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452 (60.6%) had FTT, 80 (10.7%) had persistent cough and/or 
fever and 40 (5.4%) had known TB exposure. Among the 51 (6.8%) 
children admitted based on TST ≥ 10 mm alone, 44 (86.3%) were 
referred at study closure. Of the 746 children, 41 were excluded from 
further analyses as missing data prevented classification by the diag-
nostic algorithm (40) and 1 child was lost to follow up1 (Fig. 3). None 
of these children had a CXR suggestive of TB, and only 1 child had 
known TB exposure. Subsequently, 705 children were included in 
further analyses. Their clinical characteristics are provided in Table 2. 
Except for CXR changes, TST and QFT test results, there were no 
significant differences in sociodemographic, clinical or nutritional 
variables between children with or without clinical TB. The mean 
age was 14.8 months, about 50% of the mothers and fathers had pri-
mary or secondary school, 76.6% lived in brick houses but only 7% 
of the families used gas to cook. Known TB exposure was present in 
12.1%. A striking 76.2% had FTT. Poor nutritional status was also 
reflected in the WHO growth chart Z scores (40–50% had wasting/
underweight and 30% had stunting) and in the proportion of children 
with moderate-severe anemia (32.8%).
Performance of TST and QFT in Clinical TB Cases
Thirteen clinical TB cases, (4 definite and 9 probable) were 
identified; 4 were TST positive and 3 QFT positive. The sensitiv-
ity of TST and QFT for clinical TB was 31% and 23%, respec-
tively (Table 3). Among children with definite TB, 3 had negative 
smears but positive cultures and were TST and QFT positive. The 
4th child with definite TB was TST and QFT negative (sensitivity 
for definite TB: 75%). This 18-month-old boy was the only child 
in our study with a positive smear (gastric aspirate grade 3+), illus-
trating the shortcomings of TST and QFT also in definite TB cases 
despite an adequate T-cell response to mitogen (>10). He had been 
initiated on anti-TB treatment 2 weeks before admission, which 
likely explains the negative culture, but MTB was confirmed by 
PCR. Of 9 children classified as probable TB, 1 infant was TST 
positive, 7 were QFT negative and 2 QFT indeterminate (Table 4).
Overall TST and QFT Results
In the 705 children, 69 of 702 (9.8%) were TST positive. QFT 
was positive in 36 and indeterminate in 22 of 691 (5.1% and 3.1%, 
respectively). Of the children with an indeterminate QFT, 19 (86.4%) 
TST ( N = 702)
  Median 4.0 7.5 4.0 0.07
  Positive (cutoff ≥10 mm) 69 (9.8) 4 (30.8) 65 (9.4) 0.031
QuantiFERON Gold In-Tube (N = 691)
  Positive (≥ 0.35 IU/mL) 36 (5.1) 3 (23.1) 33 (4.8) 0.003
  Negative (< 0.35 IU/mL) 633 (89.8) 8 (61.5) 625 (90.3)
  Indeterminate 22 (3.1) 2 (15.4) 20 (2.9)
  Mitogen minus nil (median) 10 10 10 0.40
  TB-antigen minus nil (median) 0.01 0.02 0.01 0.29
*Comparison of distribution between infants with and without clinical TB disease performed by t test, Mann-Whitney U test or Fisher’s Exact test where appropriate. Two-sided 
P values < 0.05 are shown in bold.
†No missing data among infants with clinical TB disease.
TABLE 2. (Continued)
Total Clinical TB† No TB
P Valuen = 705 (%) n = 13 (%) n = 692 (%)
FIGURE 3. Flow-chart for the 746 study 
participants. The diagnostic procedures 
applied at the *CVW are listed.
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were aged <12 months and the remaining 3 (13.6%) were aged 12–23 
months. The difference in the distribution of indeterminate results 
within the 3 age categories was thus highly significant (Fisher’s Exact 
test, P < 0.0005). Low mitogen response was the predominant cause 
of an indeterminate QFT result seen in 21 children (95.5%). Notably, 
indeterminate QFT was more frequent in children with clinical TB 
(15%) compared with children without (3%).
TST and QFT Agreement
Valid results for both TST and QFT were obtained in 666 chil-
dren. The 39 children without corresponding TST and QFT results 
were thus omitted from this analysis. Agreement between the tests 
was only fair [κ = 0.30, 95% confidence intervals (CI): 0.18–0.42], 
indicating that exchanging 1 test for the other is unlikely to provide 
the same information. When restricted to those with known TB expo-
sure, which increases the pretest probability of the tests, the agree-
ment was substantial (κ = 0.75, 95% CI: 0.42–0.95; Table 5). This 
highlights the importance of focusing on TB exposure rather than 
immunological tests in young pediatric populations.
Determinants for a Positive TST and/or QFT
Unadjusted odds ratio (OR) estimates for the variables: surveil-
lance arm (active or passive), gender, birth weight, SGA, age, socio-
economic factors (mothers/fathers education, housing, cooking fuel), 
known TB exposure, symptoms, nutritional status (WHZ, HAZ, WAZ, 
BAZ and anemia) and isolated NTMs were performed by logistic 
regression. If significant, these estimates, with 95% CIs, are presented 
in Tables 1 and 6 together with unadjusted and adjusted analyses for 
all variables included in the final multivariate model: gender, age (cat-
egorical), known TB exposure, nutritional status (WHZ, HAZ) and 
NTM isolated from culture. Data not shown are available on request.
Adjusted for the other factors, boys had increased OR for 
a positive TST. Younger age associated negatively with a positive 
TST and/or QFT, more prominently with TST than QFT, both 
in children <12 and 12–23 months compared with children ≥24 
months. TB exposure was a determinant for a positive TST and/or 
QFT. Within the study population, having a WHZ < −2.59 reduced 
the OR for a positive TST whereas having a HAZ < −2.14 increased 
the OR for a positive QFT and positivity for both tests, but not for 
TST alone. Birth weight < 2500 g and SGA were included in the 
models one at a time, but no significant associations was present 
and the other coefficients remained unchanged (data not shown). 
All possible 2-way interactions in the models were tested, but only a 
slight interaction between WHZ and HAZ (P = 0.048) for a positive 
QFT was found. The model including the interaction gave a better 
fit (Likelihood Ratio test Statistics: χ2 = 5.34, P < 0.025), but did 
not change the coefficients. Stratified analyses indicated that the 
effect of having a HAZ <−2.14 on a positive QFT was not evident 
in children with WHZ <− 2.59 (OR: 0.55, 95% CI: 0.06–5.13 vs. 
OR: 4.0, 95% CI: 1.71–9.35).
Determinants for an Indeterminate QFT
Results from unadjusted and adjusted analyses are given in 
Table 7. The multivariate model included gender, age (continuous), 
fever and/or cough of any duration, nutritional status (WHZ and HAZ) 
and NTM isolated from culture. Adjusted for the other factors, the OR 
of an indeterminate result was reduced by 0.83 with every month of 
age (95% CI: 0.76–0.90). Fever and cough as well as a HAZ within 
the lowest quartile increased the OR for an indeterminate QFT. Neither 
birth weight <2500 g nor SGA showed any association or changed the 
other coefficients and were therefore omitted in the final model.
The Impact of Alternative Nutritional Variables on 
TST and QFT Outcomes
WAZ and BAZ are alternative markers of nutritional status 
and indicate underweight if the Z score is <−2.6 Exchanging WHZ 
and HAZ for WAZ or BAZ in the multivariate models, WAZ (cutoff 
<−2.63) and BAZ (cutoff<−2.51) acted similarly by reducing the 
OR for a positive TST (ORWAZ 0.35, 95% CI: 0.16–0.77; ORBAZ 
0.20, 95% CI: 0.07–0.54) and increased the OR for an indetermi-
nate QFT result (ORWAZ 4.00, 95% CI: 1.61–9.95; ORBAZ 3.02, 
95% CI: 1.23–7.44) in children with Z scores below the cutoff.
DISCUSSION
To our knowledge, this is the first extensive study of TST 
and QFT performance in young Indian children. The sensitivities of 
TST and QFT test for clinical TB were equally poor, which may be 
attributable to the influence of younger age and malnutrition. QFT 
results did not add significantly to the information already provided 
by TST, supporting current WHO guidelines in high-burden TB set-
tings.2 We report for the first time that a low HAZ score, which 
indicates stunting, a result of chronic malnutrition, is a determinant 
for an indeterminate QFT result when corrected for other factors.
The sensitivities of TST and QFT for clinical TB were 31% 
and 23%, which is comparable with studies conducted in young 
African children.13–16 The diagnostic criteria in this study are 
slightly less stringent than recently recommended by an expert 
panel,17 but the proportion of confirmed TB cases (30%) is similar 
to other studies of pediatric TB.18 The lack of a gold standard for 
MTB infection and the diagnosis of smear and culture-negative TB 
complicates the evaluation of TST and QFT performance.
TABLE 3. The Performance of the TST and the QFT in the Diagnosis of Clinical TB Disease
TB Status
Sensitivity Specificity PPV† NPV‡ κ (95% CI)*
Clinical TB No TB
N N
TST
  ≥10 mm 4 65 30.8% 90.6% 5.8% 98.6% 0.07
  <10 mm 9 624 (4/13) (624/689) (4/69) (624/633) (−0.02 to 0.16)
QFT
  ≥0.35 IU/mL 3 33 23.1% 92.2% 8.3% 98.7% 0.11
  <0.35 IU/mL 8 625 (3/13) (625/678) (3/36) (625/633) (−0.02 to 0.27)
 Indeterminate 2 20
*Indeterminate QFT results are excluded from analysis of kappa agreement. 
†Positive predictive value.
‡Negative predictive value.  
CI that do not overlap the null value κ = 1 are shown in bold.
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Determining the clinical relevance of bacteriologically uncon-
firmed TB is an important issue in pediatric TB. Because pediatric 
TB is often paucibacillary,1 it can be argued that false negative QFT 
results could be expected, as increasing evidence supports a positive 
association between the antigen load and the magnitude of MTB-
specific IFNγ responses.19,20 Accordingly, children with sputum-neg-
ative TB could simply be in the early stages of TB. Given that cases 
in this study were identified by active case finding, this is very likely.1 
Although published studies indicate an increased risk of TB disease 
in subjects with TST indurations ≥12 mm21 or high IFNγ-responses 
after recent infection,19,20 these studies were conducted almost 
entirely in adults. Interestingly, adults with discordant TST and 
IGRA results had the lowest rates of TB in a household contact study 
in the Gambia.20 From this perspective, one could argue that there is 
an over diagnosis of TB in young children. However, epidemiologi-
cal estimates suggest the opposite1 and TST and/or QFT negativity is 
not restricted to unconfirmed TB cases,13,15,16,22 as shown in this study. 
Furthermore, we report increased OR for indeterminate QFT in chil-
dren with intercurrent disease (fever and/or cough of any duration). 
This questions the validity of extrapolation of immune responses in 
asymptomatic, latently infected adults, to immune responses in sick 
children. Moreover, unlike adults, children <2 years at time of infec-
tion who progress to TB can almost universally be assumed to do 
so after a primary infection.1 The nature of a primary and/or imma-
ture immune response23 could cause MTB-specific, IFNγ-producing 
T-cells to be present in lower numbers in young children.
Ideally, determinants for TST and QFT outcomes should be 
evaluated in clinical TB cases, but this is possible only in prospective 
community-based settings where the TB incidence is high. There-
fore, we evaluated associations between determinants and TST/QFT 
results regardless of TB disease status. As expected, known TB expo-
sure associated with a positive TST and/or QFT when corrected for 
other factors. Our study indicates that there might be factors which 
mask the true relationship between known TB exposure and a posi-
tive TST since this association was evident only in adjusted analysis.
Boys were more likely to be TST positive than girls when 
corrected for other factors. Basu et al24 recently reported that boys 
were more likely to be QFT positive, but found no such association 
with TST. There are well-known gender differences in TB epide-
miology, but it is unclear to which extent these are attributable to 
genetic as opposed to socioeconomic and cultural factors.25
Children <2 years were less likely to be TST and/or QFT posi-
tive and more likely to have an indeterminate QFT result than children 
aged 2–3 years. This is not surprising as the immune responses in 
infancy are considered immature and evolving.23 Previous findings in 
young children are contradictory with regard to a positive associa-
tion between age and a positive TST.14,24 Regarding QFT, some stud-
ies reported no association with age, but few young children were 
included.16,26 In a large study of children <5 years, age associated posi-
tively with a positive TST and QFT after adjusting for Calmette-Gué-
rin bacillus vaccination and gender.24 Many studies have suggested 
indeterminate QFT to be more frequent in young individuals.16,22,24
The burden of malnutrition in this study was considerable. 
Malnourished children are more susceptible to infections because 
of altered immune responses27 and would thus be expected to 
have increased susceptibility to MTB infection and subsequently 
an increased rate of positive TST and/or QFT. On the other hand, 
blunted immune responses by malnutrition are likely to cause sub-
optimal performance of immunological tests as reported for immu-
nocompromised children.28 We report that HAZ <−2.16 increased 
the OR for a positive TST and/or QFT, when corrected for other 
factors. A HAZ <−2 is a marker of stunting, the result of chronic 
malnutrition. Our findings therefore confirm the increased suscep-
tibility to MTB infection in children with chronic malnutrition. At T
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the same time, chronic malnutrition makes these children more 
prone to indeterminate QFT, overwhelmingly because of lower 
mitogen-driven responses. Together with our finding of a sub-
stantially reduced OR for a positive TST when WHZ was <−2.61, 
our study provides strong evidence of a blunted immune response 
in malnourished children. The clinical consequences of blunted 
immunity are demonstrated by a higher mortality in hospitalized 
children with indeterminate QFT, regardless of the underlying dis-
ease.16 Studies on the effect of malnutrition on TST are conflict-
ing,29,30 but reduced sensitivity of TST for clinical TB in children 
with WAZ <−2 have been reported.13 Few studies (all evaluating 
WAZ <−2 without considering other Z scores) have evaluated mal-
nutrition as a determinant for QFT results.16,26 The definitions of 
malnutrition in studies vary considerably, and conflicting results 
might be attributed to different effects of chronic and subacute 
malnutrition. Furthermore, the standard Z score cutoff <−2 has not 
been evaluated with regard to immunological changes related to 
malnutrition. We have demonstrated that the effect of malnutrition 
depends on the variable used. When WAZ or BAZ replaced WHZ 
and HAZ in our adjusted models, the effect of chronic malnutrition 
on a positive QFT result was lost.
Children with at least 1 NTM isolated from culture (23.5%) 
had no increased OR for being TST positive when corrected for 
other factors, suggesting that reduced specificity of TST by NTM 
cross-reactivity plays little role in this setting. Similarly, no appar-
ent impact of NTM on TST was reported in Gambian children.31 
TABLE 5. Kappa Agreement (κ)* Between the QFT and the TST in A: All 
Children Tested With Both Tests; B: Children With Known TB Exposure
A: TST, All (N = 688)
B: TST, Children With Known TB 
Exposure (N = 79)
≥10 mm, N (%) <10 mm, N (%) ≥10 mm, N (%) <10 mm, N (%)
QFT
  ≥0.35 IU/mL 18 (26.9) 18 (2.9) 7 (63.6) 1 (1.5)
  <0.35 IU/mL 48 (71.6) 582 (93.7) 3 (27.3) 65 (95.6)
  Indeterminate 1 (1.5) 21 (3.4) 1 (9.1) 2 (2.9)
κ (95% CI) 0.30 (0.18–0.42) 0.75 (0.42–0.95)
*Indeterminate QFT results are excluded from analysis of kappa agreement. CI that do not overlap the null value 
κ = 1 are shown in bold.
TABLE 6. Unadjusted OR Estimates and 95% CI for Significant Associations Between a Positive TST or QFT 
as Dependant Variables and Sociodemographic, Clinical, Nutritional and Mycobacteriological Factors (Not M. 
tuberculosis)*
TST ≥ 10 mm vs. TST < 10 mm 
 (N = 702)
QFT ≥ 0.35 IU/mL vs. QFT < 0.35 IU/mL  
(N = 669)
Unadjusted Adjusted Unadjusted Adjusted
 OR (95% CI)  OR (95% CI)  OR (95% CI)  OR (95% CI)
Surveillance
  Active 0.12 (0.07–0.21) 0.33 (0.16–0.70)
Gender
  Male 1.54 (0.92–2.56) 1.91 (1.03–3.53) 1.47 (0.74–2.93) 1.55 (0.76–3.17)
Age categories
  0–11 months 0.05 (0.02–0.10) 0.04 (0.02–0.08) 0.31 (0.13–0.75) 0.34 (0.13–0.86)
  12–23 months 0.05 (0.03–0.09) 0.05 (0.02–0.09) 0.23 (0.11–0.51) 0.25 (0.11–0.56)
  ≥ 24 months†
Fathers education
  High school or higher 2.06 (0.84–5.01) 0.83 (0.32–2.17)
  Primary, secondary 2.31 (1.01–5.27) 0.79 (0.34–1.8)
  Illiterate†
Known contact with TB case
  Yes 1.62 (0.83–3.15) 2.60 (1.14–5.93) 2.37 (1.04–5.42) 3.03 (1.26–7.28)
FTT
  Yes 0.16 (0.10–0.27) 0.48 (0.24–0.98)
WHZ
  <−2.59 (n = 173) 0.22 (0.09–0.55) 0.17 (0.06–0.47) 0.90 (0.40–2.02) 0.94 (0.41–2.15)
HAZ
  <−2.14 (n = 176) 1.71 (1.01–2.90) 1.42 (0.74–2.71) 2.57 (1.30–5.08) 2.46 (1.19–5.06)
BAZ
  <−2.51 (n = 175) 0.21 (0.09–0.54) 0.75 (0.32–1.76)
NTM
  ≥1 positive specimen 0.46 (0.22–0.95) 0.46 (0.20–1.04) 1.05 (0.48–2.27) 1.12 (0.78–1.12)
Adjusted OR estimates and 95% CI are shown for all variables included in the multivariate model. Odds ratio estimates and 95% CI for variables not included in the table are 
available on request.
*Binary logistic regression was applied. CI that do not overlap the null value OR = 1 are shown in bold.
†Reference group.OR
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QFT (positive/indeterminate) was not influenced by the presence of 
NTM, and all children with RD1-positive NTM (M. kansasii) were 
QFT negative. No child fulfilled the ATS/IDSA criteria32 for NTM 
disease, suggesting that NTMs were commensals in this setting.
The strength of this study is the community-based prospec-
tive design with a considerable number of enrolled children in a 
country with high TB burden but low HIV prevalence (<1%; TB 
Trials Study Group, unpublished data). This “real-life” context 
makes our findings very clinically relevant. The high prevalence 
of malnutrition and colonization by NTMs may limit the generaliz-
ability to other settings, but these conditions are typical for many 
areas with high-to-moderate TB burden. The prevalence of helminth 
infection is presumably high33 and might interact with host immune 
responses,34,35 but we were unable to collect stool samples in this 
cohort. Well-quantified TB exposure is a reliable surrogate measure 
of MTB infection,36 as reflected in this study by the increased kappa 
agreement between TST and QFT when the analysis was restricted 
to TB-exposed children. Unfortunately, graded data on TB expo-
sure was not available in this study. TST ≥ 10 mm outcome was 
both a referral criteria and 1 of 4 diagnostic criteria (≥1 criteria in 
addition to characteristic CXR changes) required for a diagnosis of 
clinical TB. The TST estimates could therefore be subject to selec-
tion bias, which is a limitation in our study. This compromise in 
design was required to avoid losing TB cases; the primary aim of 
the NCS was to establish the true incidence of TB in this cohort as 
part of preparing the site for future vaccine trials. This selection 
bias could result in an overestimation of the TST’s sensitivity for 
clinical TB, but as none of the probable TB cases depended on a 
positive TST for their diagnosis, this does not affect the TST sen-
sitivity estimate. Furthermore, compared with the OR estimates of 
the associations between a positive TST and the assessed variables, 
the OR estimates for a positive QFT outcome may be overestimated 
because TST−QFT+ discordant positives children within the NCS 
were only referred if they had known TB exposure or were symp-
tomatic, whereas TST+QFT− children might have had no other 
referral criteria. Notably, referral based on a positive TST only was 
present in 51 of 746 children, which limits this effect.
CONCLUSIONS
This study highlights that in assessing children with sus-
pected TB, it is vital to keep in mind the potential for poorer TST 
and QFT performance in the most vulnerable, namely the young 
and/or malnourished. Accordingly, the implementation of WHO’s 
treatment recommendations should be intensified.37 Withholding 
treatment in exposed and/or TST/IGRA positive but otherwise 
healthy children can only be justified if careful clinical follow up is 
possible. TST and QFT are immunological tests of cellular immu-
nity, which provide indirect evidence of MTB infection. Currently, 
extensive research is aimed at identifying immunologic biomark-
ers for diagnostic purposes, with a strong emphasis on cellular 
immunity. Better diagnostic accuracy in this population is badly 
needed, but based on the results of this study, we suggest that age 
and malnutrition are likely to influence the performance of all cel-
lular immunological markers. Future research on other approaches 
than host cell-mediated immune markers might prove more fruitful 
in this population.
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